The benefits of GLP-1s dont come without side effects
For example, Changpusan has demonstrated significant antidepressant effects in the CUMS model, with its impact on tryptophan metabolism confirmed through metabolomic profiling [547]
But if the patient develops, say, cardiovascular problems over the years because of that obesity, we are going to finance a stent for their arteries, we are going to pay for heart surgery
Studies show that single-molecule dual GIPR/GLP-1R agonists have better insulinotropic and antihyperglycemic effects than GLP-1 agonists in rodents, primates, and humans, without causing gastrointestinal disturbances [58]
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes